cucumarioside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cucumarioside: from Cucumaria (sea cucumbers); RN given refers to cpd with unknown MF [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	3085992
MeSH ID	M0103904

Synonyms (2)

Synonym
74434-21-2
cucumarioside

Research Excerpts

Overview

Cucumarioside A(2)-2 is a pentaoside having glucose as a third monosaccahride unit.

Excerpt	Reference	Relevance
"Cucumarioside A(2)-2 is a pentaoside having glucose as a third monosaccahride unit."	( Differential effects of triterpene glycosides, frondoside A and cucumarioside A2-2 isolated from sea cucumbers on caspase activation and apoptosis of human leukemia cells. Avilov, SA; Fedorov, SN; Jin, JO; Kwak, JY; Park, JI; Rasskazov, VA; Shastina, VV; Shin, SW; Stonik, VA; Xu, Q, 2009)	1.31

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	2 (11.11)	18.7374
1990's	4 (22.22)	18.2507
2000's	3 (16.67)	29.6817
2010's	8 (44.44)	24.3611
2020's	1 (5.56)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	11.68 (24.57)
Research Supply Index	3.30 (2.92)
Research Growth Index	4.97 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	26 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes
3-o-methylglucose 3-O-Methylglucose: A non-metabolizable glucose analogue that is not phosphorylated by hexokinase. 3-O-Methylglucose is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems. (J Neurochem 1993;60(4):1498-504). 3-O-methyl-D-glucose : A D-aldohexose that is D-glucose in which the hydrogen of the hydroxy group at position 3 has been substituted by a methyl group. It is a non-metabolisable glucose analogue that is not phosphorylated by hexokinase and is used as a marker to assess glucose transport by evaluating its uptake within various cells and organ systems.	1.99	1	D-aldohexose derivative
fluorescein-5-isothiocyanate Fluorescein-5-isothiocyanate: Fluorescent probe capable of being conjugated to tissue and proteins. It is used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques.. fluorescein 5-isothiocyanate : The 5-isomer of fluorescein isothiocyanate. Acts as a fluorescent probe capable of being conjugated to tissue and proteins; used as a label in fluorescent antibody staining procedures as well as protein- and amino acid-binding techniques.	2.05	1	fluorescein isothiocyanate
glycosides [no description available]	4.27	18
beta-escin [no description available]	2.47	2
cucumarioside a2-2 cucumarioside A2-2: isolated from Cucumaria japonica; structure in first source	7.05	1
holothurin Holothurin: A highly toxic saponin occurring in HOLOTHUROIDEA. This marine toxin is an anionic surfactant, hemolyzing ERYTHROCYTES.	2.38	2
frondoside a frondoside A: from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa	7.05	1

Condition	Relationship Strength	Studies
Breast Cancer [description not available]	2.6	1
Breast Neoplasms Tumors or cancer of the human BREAST.	2.6	1
Carcinoma, Ehrlich Tumor A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.	2.52	2
Leucocythaemia [description not available]	2.05	1
Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)	7.05	1
Extravascular Hemolysis [description not available]	2.95	4
Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.	2.95	4
Delayed Hypersensitivity [description not available]	2.03	1
Infections, Staphylococcal [description not available]	2.03	1
Far East Scarlet-like Fever [description not available]	2.03	1
Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS.	2.03	1
Salmonella Infections, Animal Infections in animals with bacteria of the genus SALMONELLA.	1.96	1
Abnormalities, Autosome [description not available]	1.97	1
E coli Infections [description not available]	1.97	1
Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.	1.97	1
Infections, Pseudomonas [description not available]	1.97	1
Infections, Proteus [description not available]	1.97	1
Escherichia coli Infections Infections with bacteria of the species ESCHERICHIA COLI.	1.97	1
Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS.	1.97	1

chemdatabank.com